David Linetsky is SVP, Life Sciences of Phreesia, Inc.. Currently has a direct ownership of 217,239 shares of PHR, which is worth approximately $5.6 Million. The most recent transaction as insider was on Jan 15, 2021, when has been sold 1,787 shares (Common Stock) at a price of $62.96 per share, resulting in proceeds of $112,510. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 217K
0.41% 3M change
6.47% 12M change
Total Value Held $5.6 Million

David Linetsky Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 15 2021
SELL
Payment of exercise price or tax liability
$112,510 $62.96 p/Share
1,787 Reduced 1.14%
154,879 Common Stock
Jan 15 2021
BUY
Grant, award, or other acquisition
-
28,589 Added 15.43%
156,666 Common Stock
Oct 01 2020
SELL
Open market or private sale
$140,488 $31.38 p/Share
4,477 Reduced 3.38%
128,077 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$6,486 $4.71 p/Share
1,377 Added 1.03%
132,554 Common Stock
Feb 21 2020
BUY
Exercise of conversion of derivative security
$2,491 $0.73 p/Share
3,413 Added 1.53%
219,250 Common Stock
DL

David Linetsky

SVP, Life Sciences
Raleigh, NC

Track Institutional and Insider Activities on PHR

Follow Phreesia, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHR shares.

Notify only if

Insider Trading

Get notified when an Phreesia, Inc. insider buys or sells PHR shares.

Notify only if

News

Receive news related to Phreesia, Inc.

Track Activities on PHR